miR‐181a/b therapy in lung cancer: reality or myth?

Despite substantial progress in oncology, lung cancer remains the number one malignancy in terms of both incidence and mortality rates, and there thus remains an urgent need for new therapeutic alternatives. MicroRNA (miRNA) have an important role in cancer initiation and progression due to their ca...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Mol Oncol
Auteurs principaux: Braicu, Cornelia, Gulei, Diana, Cojocneanu, Roxana, Raduly, Lajos, Jurj, Ancuta, Knutsen, Erik, Calin, George Adrian, Berindan‐Neagoe, Ioana
Format: Artigo
Langue:Inglês
Publié: John Wiley and Sons Inc. 2019
Sujets:
Review Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6322195/
https://ncbi.nlm.nih.gov/pubmed/30548184
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/1878-0261.12420
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires